Wolverine Stack Protocol: Recovery Blend Guide
Also known as: Wolverine Stack, BPC-157 + TB-500 Blend (1:1), 5mg/5mg or 10mg/10mg Recovery Blend
Studied in published research — not a medical recommendation. Primary protocol (1:1 Pre-Mixed Blend Protocol (5mg/5mg or 10mg/10mg Vial)): 250–500 mcg BPC-157 + 250–500 mcg TB-500, Once daily or split 250mcg/250mcg AM & PM.
Once daily or split 250mcg/250mcg AM & PM
Research-reported range (no primary dosing study). With a 5mg/5mg vial + 2mL BAC water, 10 units (0.10mL) = 250mcg BPC-157 + 250mcg TB-500
Subcutaneous injection
Published peer-reviewed research & clinical protocols
No verified human half-life on file for this compound
A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.
All U-100: 100 units = 1 mL. 20 doses in the vial at the low end (10 doses at the high end).
Save Wolverine Blend (BPC-157 + TB-500) to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.
Wolverine Blend (BPC-157 + TB-500) supplier & $/mg comparison.
At a Glance · 2026 FDA / 503A / WADA / Evidence Profile
Bottom Line Up Front
The Wolverine Stack pairs BPC-157 (pentadecapeptide) with TB-500 (Thymosin Beta-4 fragment). Pre-mixed vials almost universally use a 1:1 ratio (5mg/5mg or 10mg/10mg dosed at 250–500 mcg each daily), whereas separate-vial protocols often run a 1:2.5 weekly ratio (500 mcg/day BPC-157 + 2.5 mg TB-500 twice weekly) to match each peptide's natural half-life.
Published preclinical & translational clinical protocols
Large multi-year outcomes in healthy non-clinical cohorts
None
3 (1 human)
EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. Wolverine Blend (BPC-157 + TB-500) is not FDA approved for human use (unless specified above). This information does not constitute medical advice.
Overview
The Wolverine Blend (BPC-157 + TB-500) is the gold-standard regenerative combination in orthopedic, athletic, and post-surgical recovery research. BPC-157 acts locally and enterically by upregulating growth hormone receptors on tendon fibroblasts and stimulating nitric-oxide/VEGFR2 angiogenesis, while TB-500 acts systemically by sequestering G-actin to drive endothelial and myoblast cell migration across injured tissue.
Mechanisms of Action
- BPC-157 activates the FAK-paxillin pathway and upregulates growth hormone receptor expression on tendon/ligament fibroblasts
- TB-500 (Thymosin Beta-4) binds G-actin to promote cell migration, stem cell recruitment, and reduced scar-tissue fibrosis
- Dual angiogenic synergy via VEGFR2 upregulation (BPC-157) and endothelial progenitor migration (TB-500)
- Downregulates pro-inflammatory cytokines (TNF-alpha, IL-6) in acute soft-tissue and joint injuries
Common Ratios, Vial Formats & Dosing Breakdown
Researchers use different ratios depending on whether they reconstitute a pre-mixed vial or draw from separate single-compound vials.
1:1 Pre-Mixed Vial (Standard Vendor Blend)
5mg BPC-157 / 5mg TB-500 (10mg total) or 10mg / 10mg (20mg total)
250–500 mcg BPC-157 + 250–500 mcg TB-500 once or twice daily
Why this ratio: Most convenient single-pin option. Reconstituting a 5mg/5mg vial with 2.0 mL BAC water yields 250 mcg of each peptide per 10 units (0.10 mL).
Separate-Vial Half-Life Protocol (Clinical/Athletic)
10mg BPC-157 vial + 10mg TB-500 vial (separate)
250–500 mcg BPC-157 daily + 2.0–2.5 mg TB-500 twice weekly
Why this ratio: Common protocol: daily BPC-157 with twice-weekly TB-500. Human half-lives for both are not established.
2:1 BPC-Dominant Tendon & Gut Ratio
10mg BPC-157 / 5mg TB-500 (15mg total)
500 mcg BPC-157 + 250 mcg TB-500 daily (split AM/PM)
Why this ratio: Used when prioritizing focal enthesopathy (golfer/tennis elbow, Achilles) or GI mucosal repair.
Research Protocols
Summaries of published research. For educational purposes only.
| Protocol Name | Source | Dose | Frequency | Duration | Route | Evidence | Link | Save |
|---|---|---|---|---|---|---|---|---|
| 1:1 Pre-Mixed Blend Protocol (5mg/5mg or 10mg/10mg Vial) | reported protocol | 250–500 mcg BPC-157 + 250–500 mcg TB-500 | Once daily or split 250mcg/250mcg AM & PM | 4–8 weeks | Subcutaneous injection | animal | — | |
| Separate-Vial Half-Life Optimized Protocol | reported protocol | 250 mcg BPC-157 (2x/day) + 2.5 mg TB-500 (2x/week) | BPC-157 daily; TB-500 Monday & Thursday | 6 weeks | Subcutaneous injection | animal | — |
Systemic Inflammation, Tissue Repair & Immune Biomarker Panel (Wolverine Blend (BPC-157 + TB-500))
Objective inflammatory, hematologic, and trace-mineral markers to quantify connective-tissue recovery, cytokine resolution, and organ safety.
hs-CRP (High-Sensitivity C-Reactive Protein)
Day 0 + Wk 6–8Why track at baseline: Quantifies baseline systemic IL-6/NF-κB inflammatory burden from tendon, joint, gut, or vascular injury.
Week 6–8 check: Target <1.0 mg/L (optimal <0.5 mg/L) by Week 6–8 as tissue inflammation resolves.
ESR (Sedimentation Rate) & Ferritin
Day 0 + Wk 6–8Why track at baseline: Tracks chronic connective-tissue and autoimmune/mucosal inflammatory activity alongside iron stores.
Week 6–8 check: Downward trend in ESR confirming structural resolution rather than temporary analgesic masking.
CBC with Differential (WBC, Neutrophil/Lymphocyte Ratio)
Day 0 + Wk 6–8Why track at baseline: Evaluates innate/adaptive immune balance (especially for Thymosin Alpha-1, Thymosin Beta-4, LL-37 & KPV).
Week 6–8 check: Balanced lymphocyte count and improved Neutrophil-to-Lymphocyte Ratio (NLR 1.2–2.0).
CMP (Liver/Kidney) + Serum Copper & Zinc Ratio
Day 0 + Wk 6–8Why track at baseline: Verifies baseline hepatic/renal function and checks Copper:Zinc balance before GHK-Cu / GLOW / KLOW protocols.
Week 6–8 check: Maintain 1:1 to 1.2:1 Zinc-to-Copper equilibrium and normal transaminases/creatinine.
Related Studies
No direct studies on Wolverine blend
Human StudyBased on individual peptide research for BPC-157, TB-500, and Thymosin Alpha-1
Limitations: No clinical trials on this specific blend
Community Outcomes
Community Data Coming Soon
Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!
Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.
Important Warnings
- •Both BPC-157 and TB-500 are prohibited at all times under the WADA S0/S2 list for tested athletes
- •Theoretical angiogenic caution in individuals with active neoplasms
- •Research use only — not FDA-approved
Where to get Wolverine Blend (BPC-157 + TB-500), baseline labs & clinician oversight.
Ascension Peptides (US Vials)
MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.
SwissChems & Limitless Biotech
Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).
Superpower Labs & 503A Telehealth
Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.
Where to buy Wolverine Blend (BPC-157 + TB-500): best verified price
Prices checked Nov 11, 2026 · sorted by $/mg · RUO
- 1. Ascension Peptides — $2.25/mg (20mg Lyophilized Vial, $45.00)
- 2. Bulletproof BioLabs — $4.75/mg (20mg BPC-157 / TB-500 10/10mg blend, $95.00)
- 3. Elite Research USA — $5.25/mg (20mg vial, $105.00)
Where is the cheapest place to buy Wolverine Blend (BPC-157 + TB-500)?
As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Ascension Peptides at $2.25/mg (20mg Lyophilized Vial, $45.00 after the 50% new-customer partner-link discount). We compared 9 US suppliers with live, checked prices.
How much does Wolverine Blend (BPC-157 + TB-500) cost per mg?
Verified US domestic prices currently range from $2.25/mg to $12.00/mg depending on supplier and vial size. Larger vials usually lower the $/mg.
How are these prices verified?
Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.
Is Wolverine Blend (BPC-157 + TB-500) approved for human use?
Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.
All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet
Peptide Reconstitution & U-100 Syringe Cheat Sheet
Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.
Vendor vs vendor: price per mg
Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.
- Ascension vs SwissChems (3 shared compounds)
- Elite vs SwissChems (3 shared compounds)
- Elite vs Ascension (26 shared compounds)
- Protide vs SwissChems (3 shared compounds)
- Protide vs Ascension (6 shared compounds)
- Ameano vs SwissChems (3 shared compounds)
- Ameano vs Ascension (4 shared compounds)
- Swift vs Ascension (23 shared compounds)
- BioLongevity vs Ascension (16 shared compounds)
- Peptyes vs SwissChems (3 shared compounds)
- Peptyes vs Elite (20 shared compounds)
- Peptyes vs Swift (17 shared compounds)
- Peptyes vs Pure (17 shared compounds)
- Peptyes vs Ascension (20 shared compounds)
Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →
Common questions
How many peptides are in the database?
100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.
Where can I compare peptide prices?
Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.